Core Insights - Repligen Corporation reported strong financial results for Q4 2025, achieving $198 million in revenue, an 18% year-over-year increase, with 14% organic growth driven by Analytics and Proteins [6][8] - The company anticipates revenue growth of 10% to 14% for the full year 2026, with guidance set between $810 million and $840 million [3][11] Financial Performance - Q4 2025 revenue reached $198 million, up from $168 million in Q4 2024, marking an 18% increase; full year 2025 revenue totaled $738 million, a 16% increase from $634 million in 2024 [6][8] - Adjusted gross profit for Q4 2025 was $104 million, compared to $85 million in Q4 2024; for the full year, adjusted gross profit was $388 million, up from $320 million [8] - GAAP net income for Q4 2025 was $13 million, compared to a loss of $34 million in Q4 2024; full year GAAP net income was $49 million, compared to a loss of $26 million in 2024 [12][34] Margin Summary - Q4 2025 GAAP gross margin improved to 52.5%, up from 23.2% in Q4 2024; full year GAAP gross margin was 52.3%, compared to 43.3% in 2024 [9] - Adjusted operating margin for Q4 2025 was 15.0%, slightly up from 14.9% in Q4 2024; full year adjusted operating margin was 13.8%, compared to 12.9% in 2024 [9][31] Strategic Initiatives - The company successfully executed its strategic priorities for 2025, achieving 14% organic growth and expanding its Analytics portfolio through M&A [7] - Repligen launched three new chromatography resins in its Proteins portfolio, reinforcing its commitment to innovation in bioprocessing [7] - Investments in the Asia-Pacific region included opening a new office in Singapore and expanding operations in Japan to support future growth [7] Financial Guidance for 2026 - Initial guidance for 2026 includes total reported revenue of $810 million to $840 million, with organic growth projected at 9% to 13% [3][11] - The company expects adjusted operating margin expansion of 150 basis points at the midpoint of its revenue guidance [3][11]
Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance